Dark

ICAD
Icad Inc
stock NASDAQ

At Close

Jul 16, 2025 3:59:30 PM EDT

3.88USD+3.887%(+0.15)190,127

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-3.73)0

After-hours

Jul 14, 2025 4:16:30 PM EDT

3.87USD+1.309%(+0.05)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 24, 2022

02:30PM EST iCAD's Breast AI Platform Earns U.S. Department Of Defense Authorization To Operate; Terms Not Disclosed Benzinga

02:26PM EST iCADs Breast AI Platform Earns U.S. Department GlobeNewswire Inc

Jan 18, 2022

07:20AM EST Guggenheim Downgrades icad to Neutral Benzinga

Jan 11, 2022

08:00AM EST iCAD Announces the Appointment of New Members to its Board of GlobeNewswire Inc

Jan 5, 2022

10:45AM EST Oppenheimer Maintains Outperform on icad, Lowers Price Target to $16 Benzinga

Jan 4, 2022

02:41PM EST Mid-Afternoon Market Update: Dow Jumps 250 Points; Avrobio Shares Slide Benzinga

12:17PM EST Mid-Day Market Update: Nasdaq Dips 250 Points; TherapeuticsMD Shares Surge Benzinga

10:58AM EST Stocks That Breached 52-Week Lows Today Benzinga

08:05AM EST iCAD Sees Q4 Sales $7.8M-$8M vs $10.7M Estimate; FY21 Sales $33.6M-$33.8M vs $36.5M Est. Benzinga

08:00AM EST iCAD Announces Estimated Q4 and Fiscal Year 2021 Revenues GlobeNewswire Inc

Dec 23, 2021

08:00AM EST iCAD, Inc. (NASDAQ: ICAD),a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will attend the 11thAnnual LifeSci Partners Corporate Access Event, being held virtually from January 5thto 7th, 2022. GlobeNewswire Inc

Dec 21, 2021

06:05AM EST iCAD Granted U.S. Patent #11,205,265 'System and method for assessing breast cancer risk using imagery' Benzinga

Dec 14, 2021

08:12AM EST iCAD Reports First Patient With Recurrent Glioblastoma Was Treated With Co.'s Xoft Axxent Electronic Brachytherapy System Benzinga

08:00AM EST Treatment marks initiation of international multicenter trial evaluating targeted radiation therapy and bevacizumab for the treatment of the most common and aggressive type of malignant brain tumor GlobeNewswire Inc

Dec 6, 2021

01:39PM EST iCAD to Participate at the Imagine AI + Healthcare Investor Summit GlobeNewswire Inc

08:20AM EST iCAD Appoints Stacey Stevens As President And CEO Benzinga

08:00AM EST iCAD Announces CEO Transition GlobeNewswire Inc

Nov 29, 2021

08:00AM EST Worlds first FDA cleared AI breast cancer detection software to be highlighted in three scientific presentations at largest radiological meeting in the world GlobeNewswire Inc

Nov 11, 2021

04:05PM EST iCAD, Inc. (NASDAQ: ICAD),a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will participate in the 12th Annual Craig-Hallum Alpha Select Conference on Tuesday, November 16, 2021, starting at 9:00 AM ET. GlobeNewswire Inc

08:00AM EST Leading clinical and administrative experts to discuss how leveraging iCADs Breast Health Solutions and the Xoft System can enhance clinical efficiency and improve outcomes for patients GlobeNewswire Inc

Nov 10, 2021

07:47AM EST JMP Securities Maintains Market Outperform on icad, Lowers Price Target to $18 Benzinga

Nov 9, 2021

06:02PM EST icad Q3 EPS $(0.09) Misses $(0.08) Estimate, Sales $9.36M Miss $9.91M Estimate Benzinga

11:25AM EST Earnings Scheduled For November 9, 2021 Benzinga

Oct 26, 2021

08:00AM EDT iCAD, Inc. (NASDAQ: ICAD),a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the third quarter ended September 30, 2021, after the market close, and host a conference call at 4:30pm Eastern Time on Tuesday, November 9. GlobeNewswire Inc

Oct 7, 2021

08:00AM EDT Leading-edge AI solution for 2D mammography enhances cancer detection performance for clinicians, with improved sensitivity, specificity, and processing times over previous versions GlobeNewswire Inc

Sep 29, 2021

08:00AM EDT Latest generation of ProFound AI Risk offers greater accuracy and ethnically inclusive precision screening GlobeNewswire Inc

Sep 9, 2021

02:46PM EDT iCAD to Host Educational Roundtable to Help Clinicians and GlobeNewswire Inc

Aug 31, 2021

08:15AM EDT iCAD Reports Its Xoft Brain Intraoperative Radiation Therapy Showed Improvement In Overall Survival For Patients With Recurrent Glioblastoma Benzinga

08:00AM EDT iCADs Xoft Brain IORT Demonstrates Significant GlobeNewswire Inc

Aug 27, 2021

05:14PM EDT Return on Capital Employed Insights for icad Benzinga

Aug 6, 2021

02:40PM EDT Mid-Afternoon Market Update: Dow Gains 140 Points; Spectrum Pharmaceuticals Shares Plummet Benzinga

12:11PM EDT Mid-Day Market Update: Gold Drops 2.5%; Sphere 3D Shares Spike Higher Benzinga

10:18AM EDT Mid-Morning Market Update: Markets Mostly Higher; US Economy Adds 943,000 Jobs Benzinga

08:09AM EDT On August 2, Charles R. Carter Was Appointed Chief Financial Officer And Secretary Of iCAD Benzinga

Aug 5, 2021

04:54PM EDT icad Q2 EPS $(0.11) Misses $(0.07) Estimate, Sales $7.83M Miss $9.15M Estimate Benzinga

04:08AM EDT Earnings Scheduled For August 5, 2021 Benzinga

Aug 2, 2021

04:05PM EDT iCAD, Inc. (NASDAQ: ICAD),a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chairman and Chief Executive Officer, and Stacey Stevens, President, will participate in a fireside chat at the Guggenheim MedTech Disruptors Summit, taking place virtually on August 9-10, 2021. GlobeNewswire Inc

Jul 22, 2021

04:01PM EDT iCAD, Inc. (NASDAQ: ICAD),a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the second quarter and six-months ended June 30, 2021, after the market close, and host a conference call at 4:30pm Eastern Time on Thursday, August 5. GlobeNewswire Inc

Jun 14, 2021

08:03AM EDT iCAD's ProFound AI for Digital Breast Tomosynthesis Version 3.0 Receives CE Mark Approval Benzinga

08:00AM EDT iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that ProFound AI Version 3.0 for Digital Breast Tomosynthesis (DBT) received CE Mark approval. GlobeNewswire Inc

Jun 8, 2021

08:12AM EDT ICAD Signs Worldwide Distribution Agreement With Sectra RTTNews

08:10AM EDT iCAD Signs Global Distribution Agreement With Sectra; Terms Not Disclosed Benzinga

08:00AM EDT iCAD Signs Global Distribution Agreement with Sectra GlobeNewswire Inc

May 17, 2021

04:05PM EDT iCAD, Inc. (NASDAQ: ICAD),a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, iCADs Chairman and Chief Executive Officer, will be participating at the following three virtual investor conferences in May and June: GlobeNewswire Inc

08:00AM EDT iCAD Announces Educational Webinar Featuring Leading Global GlobeNewswire Inc

Apr 28, 2021

04:12PM EDT icad Q1 EPS $(0.07) Beats $(0.11) Estimate, Sales $8.60M Beat $7.92M Estimate Benzinga

04:01PM EDT First Quarter Revenues of $8.6 Million Represented 32% Year-Over-Year Growth Driven by 28% Growth in Detection Revenue and 41% Growth in Therapy Revenue GlobeNewswire Inc

04:15AM EDT Earnings Scheduled For April 28, 2021 Benzinga

Apr 22, 2021

01:58PM EDT Icad shares were trading higher after Guggenheim initiated coverage on the stock with a Buy rating and a price target of $24 per share. Benzinga

01:40PM EDT Guggenheim Initiates Coverage On icad with Buy Rating, Announces Price Target of $24 Benzinga

Apr 20, 2021

04:01PM EDT iCAD, Inc. (NASDAQ: ICAD),a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the first quarter ended March 31, 2021, after the market close, and host a conference call at 4:30pm Eastern Time on Wednesday, April 28. GlobeNewswire Inc

Apr 19, 2021

08:03AM EDT iCAD Highlights Presentation Of Data At Society Of Breast Imaging Symposium Apr. 9-11 And National Consortium Of Breast Centers Annual Interdisciplinary Breast Center Conference Apr. 16-19 Benzinga

08:00AM EDT New Research Confirms iCADs ProFound AI Aids GlobeNewswire Inc

Apr 6, 2021

09:57AM EDT Icad shares were trading lower after the company issued Q1 preliminary results. Benzinga

Apr 5, 2021

04:02PM EDT iCAD Announces CFO Departure; Co. Searching For Successor Benzinga

04:02PM EDT iCAD Expects Prelim. Q1 Sales To Exceed $8.1M vs $7.89M Est. Benzinga

04:01PM EDT Company expects preliminary estimated revenues to exceed $8.1 million GlobeNewswire Inc

Mar 31, 2021

08:06AM EDT iCad Highlights Retrospective Analysis That Co's ProFound AI For 2D Mammography Might 'Notably Reduce The Risk Of Interval Breast Cancer' Benzinga

08:00AM EDT iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that ProFound AI for 2D Mammography might notably reduce the risk of interval breast cancer, according to a retrospective analysis recently published in the Journal of Medical Screening.1 GlobeNewswire Inc

Mar 23, 2021

02:39PM EDT ICAD Focuses On Areas Of High Unmet Need In Cancer Detection, BTIG Says Benzinga

11:25AM EDT Icad shares were trading higher after BTIG initiated coverage on the stock with a Buy rating and a price target of $25 per share. Benzinga

10:04AM EDT Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2021 Benzinga

06:23AM EDT BTIG Initiates Coverage On icad with Buy Rating, Announces Price Target of $25 Benzinga

Mar 16, 2021

07:42AM EDT iCAD Shares On The Rise After FDA Approval For Third Version Of ProFound AI For 3D Mammography Benzinga

Mar 15, 2021

06:05PM EDT Companys third generation AI solution offers significant improvement in algorithm specificity performance and faster processing compared to previous versions of the software GlobeNewswire Inc

Mar 8, 2021

12:37PM EST iCAD Press Release Highlights New Research Supporting ProFound AI Presented At European Congress Of Radiology Online Meeting Mar. 3-10, 2021 Benzinga

12:36PM EST Company showcased expanded ProFound AI platform, including ProFound AI Risk, the worlds first clinical decision support tool that provides a highly accurate short-term risk estimation specific to each woman GlobeNewswire Inc

08:46AM EST iCAD Announces Closing of $25.0 Million Public Offering of Common GlobeNewswire Inc

Mar 3, 2021

09:16PM EST iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, iCADs Chairman and Chief Executive Officer, will deliver a formal presentation at the Cowen 41st Annual Health Care Conference on Thursday, March 4th at 12:10pm ET and will also conduct one-on-one meetings with investors. GlobeNewswire Inc

10:29AM EST Shares of iCAD, Inc. (ICAD) are gaining over 10% on Wednesday morning. The medical technology company announced the pricing of $22.0 million public offering of common stock. RTTNews

12:48AM EST iCAD Announces Pricing of $22.0 Million Public Offering of Common GlobeNewswire Inc

Mar 2, 2021

04:04PM EST iCAD Announces Proposed Public Offering of Common; No Terms Disclosed Benzinga

04:01PM EST iCAD Announces Proposed Public Offering of Common Stock GlobeNewswire Inc

Feb 26, 2021

10:04AM EST Benzinga's Top Ratings Upgrades, Downgrades For February 26, 2021 Benzinga

06:36AM EST Oppenheimer Initiates Coverage On icad with Outperform Rating, Announces Price Target of $27 Benzinga

Feb 24, 2021

04:12PM EST icad Q4 EPS $(0.07), Inline, Sales $10.50M Beat $7.99M Estimate Benzinga

04:01PM EST Fourth Quarter Revenues of $10.5 Million Represented 47% Sequential Growth Driven by 70% Growth in ProFound AI Product Revenue GlobeNewswire Inc

03:35AM EST Earnings Scheduled For February 24, 2021 Benzinga

Feb 16, 2021

04:01PM EST iCAD to Participate in the BTIG Virtual MedTech, Digital Health, GlobeNewswire Inc

Jan 29, 2021

10:04AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 29, 2021 Benzinga

06:19AM EST Cantor Fitzgerald Initiates Coverage On icad with Overweight Rating, Announces Price Target of $19 Benzinga

Jan 19, 2021

08:00AM EST iCAD to Participate in B. Riley Securities Virtual Oncology GlobeNewswire Inc

Jan 6, 2021

04:01PM EST iCAD, Inc. (NASDAQ: ICAD),a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will participate in the 10thAnnual LifeSci Partners Corporate Access Event,January 6-8and 11-14, 2021. GlobeNewswire Inc

Dec 29, 2020

05:54PM EST iCAD Announces Renowned Neuro-Oncologist Santosh Kesari, MD, PhD GlobeNewswire Inc

Dec 28, 2020

02:18PM EST iCAD 13D Filing From Portolan Capital Shows New 5.1% Stake In Co. Benzinga

Dec 10, 2020

08:00AM EST Solis Mammography Adopts iCADs ProFound AI GlobeNewswire Inc

Dec 3, 2020

08:00AM EST Leading Clinical Experts Discuss Advancing Personalized Breast Cancer Screening and Detection with Newly Launched ProFound AI Risk GlobeNewswire Inc

Nov 30, 2020

08:00AM EST iCAD Highlights Expanded Suite of Leading Breast Health AI GlobeNewswire Inc

Nov 25, 2020

08:00AM EST iCAD Announces Promising Clinical Data to be Presented on GlobeNewswire Inc

Nov 24, 2020

08:09AM EST iCAD Reports Over 1,000 Licenses Sold As Part Of ProFound AI Sales Benzinga

08:00AM EST Significant Percentage of Licenses Sold to Facilities with GE, Siemens, and Sites with Multiple Vendors Including Hologic and Fuji GlobeNewswire Inc

Nov 5, 2020

04:22PM EST icad Q3 EPS $(0.08) Beats $(0.11) Estimate, Sales $7.13M Beat $6.17M Estimate Benzinga

04:34AM EST Earnings Scheduled For November 5, 2020 Benzinga

Oct 29, 2020

08:28AM EDT iCAD, Inc. (NASDAQ: ICAD),a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the third quarter ended September 30, 2020, after the market close, and host a conference call at 4:30pm Eastern Time on Thursday, November 5. GlobeNewswire Inc

Oct 23, 2020

05:01PM EDT New Research Presented at Virtual ASTRO Meeting Supports Xoft GlobeNewswire Inc

Oct 20, 2020

08:17AM EDT ICAD Signs Distribution Agreement With Change Healthcare RTTNews

08:16AM EDT iCAD Signs Distribution Agreement with Change Healthcare To Expand Access To ProFound AI For More Hospitals And Imaging Centers Across North America Benzinga

08:00AM EDT iCAD Signs Distribution Agreement with Change Healthcare GlobeNewswire Inc

Oct 19, 2020

08:04AM EDT iCAD Highlights Presentation Of Clinical Results Supporting Xoft Axxent Electronic Brachytherapy System For Recurrent Glioblastoma Benzinga

08:00AM EDT New Data Supports iCADs Xoft Brain IORT as GlobeNewswire Inc

Oct 16, 2020

08:00AM EDT iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will host a technology innovation webinar on the current treatment landscape and unmet medical needs for treating cancer, on Wednesday, October 21, 2020, at 10am Eastern Time. GlobeNewswire Inc

Sep 21, 2020

10:21AM EDT Mid-Morning Market Update: Markets Open Lower; Microsoft To Acquire Game Maker ZeniMax For $7.5B Benzinga

Sep 20, 2020

09:26PM EDT ICAD :IORT Reimbursement Unchanged; Payment Values For Alternative, Longer Courses Of Radiation Therapy Reduced RTTNews

09:03PM EDT iCAD Responds to CMS' Finalized Radiation Oncology Alternative Payment Model Benzinga

09:00PM EDT iCAD Responds to CMS Finalized Radiation GlobeNewswire Inc

Sep 18, 2020

04:29PM EDT -- Existing Reimbursement Codes Will Still Apply in All Geographic Markets -- iCAD Intends to Submit Additional Long-Term Data in Support of IORTs Inclusion and Petition CMS for Reconsideration GlobeNewswire Inc

12:08PM EDT ICAD icad Option Alert: Nov 20 $10 Calls Sweep (9) near the Ask: 123 @ $2.7 vs 0 OI; Earnings 10/28 Before Open [est] Ref=$11.55 Benzinga

Sep 15, 2020

08:03AM EDT iCAD Highlights Data Supporting Launch Of Commercially-Available Technology To Provide Short-Term Breast Cancer Risk Assessment Benzinga

08:00AM EDT ProFound AI Risk allows for detection of cancers between screenings based on data from prestigious academic medical center, Karolinska Institutet GlobeNewswire Inc

Sep 9, 2020

08:00AM EDT iCADHosts Free Virtual Roundtable Event Focusing on GlobeNewswire Inc

Aug 27, 2020

08:01AM EDT iCAD, Inc. (NASDAQ: ICAD),a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that management will present at the LD 500 Virtual Conference, hosted by LD Micro and taking place virtually September 1 4, 2020. GlobeNewswire Inc

Aug 10, 2020

04:01PM EDT iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chairman and Chief Executive Officer, will present a corporate overview at the Guggenheim MedTech Disruptors Summit, taking place virtually on August 10-11, 2020. GlobeNewswire Inc

Aug 4, 2020

04:08PM EDT icad Q2 EPS $(0.12) Beats $(0.22) Estimate, Sales $5.57M Beat $4.23M Estimate Benzinga

04:01PM EDT iCAD Reports Financial Results for Second Quarter and Six Months GlobeNewswire Inc

05:19AM EDT Earnings Scheduled For August 4, 2020 Benzinga

Jul 28, 2020

04:01PM EDT iCAD, Inc. (NASDAQ: ICAD),a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the second quarter and six-months ended June 30, 2020, after the market close, and host a conference call at 4:30 pm Eastern Time on Tuesday, August 4. GlobeNewswire Inc

Jul 20, 2020

08:00AM EDT iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced Jeffrey Sirek was appointed as Senior Vice President and General Manager of Xoft. GlobeNewswire Inc

Jul 15, 2020

08:04AM EDT iCAD Announces ProFound AI Risk Receives CE Mark In Europe Benzinga

08:00AM EDT First and only commercially available clinical decision support tool provides accuratetwo-year breast cancer risk estimation personalized for each woman GlobeNewswire Inc

Jul 13, 2020

08:00AM EDT iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, and SimonMed Imaging, one of the largest outpatient medical imaging providers and largest physician radiology practices in the United States, today announced that ProFound AI will be deployed throughout SimonMed Imagings network. GlobeNewswire Inc

document.getElementById("LhqVS8").onerror = function(){this.style.display='none';}; .dark-mode .PL4cy6{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .PL4cy6{ color: #333333; background-color: white; border: 2px solid #333333; }ICADIcad Incstock NASDAQ

ICAD
Icad Inc
stock NASDAQ